FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3138987997> ?p ?o ?g. }

• W3138987997 endingPage "174" @default.
• W3138987997 startingPage "160" @default.
• W3138987997 abstract "Chemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating adverse event that can alter patient treatment options and halt candidate drug development. A case study is presented here describing the preclinical and clinical development of CC-90003, a small molecule extracellular signal-regulated kinase (ERK)1/2 inhibitor investigated as an oncology therapy. In a Phase Ia clinical trial, CC-90003 elicited adverse drug-related neuropathy and neurotoxicity that contributed to discontinued development of CC-90003 for oncology therapy. Preclinical evaluation of CC-90003 in dogs revealed clinical signs and electrophysiological changes consistent with peripheral neuropathy that was reversible. Mice did not exhibit signs of neuropathy upon daily dosing with CC-90003, supporting that rodents generally poorly predict CIPN. We sought to investigate the mechanism of CC-90003-induced peripheral neuropathy using a phenotypic in vitro assay. Translating preclinical neuropathy findings to humans proves challenging as no robust in vitro models of CIPN exist. An approach was taken to examine the influence of CIPN-associated drugs on human-induced pluripotent stem cell-derived peripheral neuron (hiPSC-PN) electrophysiology on multielectrode arrays (MEAs). The MEA assay with hiPSC-PNs was sensitive to CIPN-associated drugs cisplatin, sunitinib, colchicine, and importantly, to CC-90003 in concordance with clinical neuropathy incidence. Biochemical data together with in vitro MEA data for CC-90003 and 12 of its structural analogs, all having similar ERK inhibitory activity, revealed that CC-90003 disrupted in vitro neuronal electrophysiology likely via on-target ERK inhibition combined with off-target kinase inhibition and translocator protein inhibition. This approach could prove useful for assessing CIPN risk and interrogating mechanisms of drug-induced neuropathy." @default.
• W3138987997 created "2021-03-29" @default.
• W3138987997 creator A5014671405 @default.
• W3138987997 creator A5021354881 @default.
• W3138987997 creator A5024475164 @default.
• W3138987997 creator A5042598436 @default.
• W3138987997 creator A5065824710 @default.
• W3138987997 creator A5088270828 @default.
• W3138987997 date "2021-03-22" @default.
• W3138987997 modified "2023-10-18" @default.
• W3138987997 title "Investigation Into the Role of ERK in Tyrosine Kinase Inhibitor-Induced Neuropathy" @default.
• W3138987997 cites W1713016576 @default.
• W3138987997 cites W1964272916 @default.
• W3138987997 cites W1984689348 @default.
• W3138987997 cites W1990693023 @default.
• W3138987997 cites W2000410352 @default.
• W3138987997 cites W2000596658 @default.
• W3138987997 cites W2004866799 @default.
• W3138987997 cites W2007252839 @default.
• W3138987997 cites W2031677735 @default.
• W3138987997 cites W2046822015 @default.
• W3138987997 cites W2057234685 @default.
• W3138987997 cites W2068750445 @default.
• W3138987997 cites W2070269476 @default.
• W3138987997 cites W2071620144 @default.
• W3138987997 cites W2084368735 @default.
• W3138987997 cites W2086262311 @default.
• W3138987997 cites W2095061238 @default.
• W3138987997 cites W2096812066 @default.
• W3138987997 cites W2105288369 @default.
• W3138987997 cites W2113927644 @default.
• W3138987997 cites W2114458368 @default.
• W3138987997 cites W2122847223 @default.
• W3138987997 cites W2133942047 @default.
• W3138987997 cites W2151772280 @default.
• W3138987997 cites W2155301275 @default.
• W3138987997 cites W2160575816 @default.
• W3138987997 cites W2170259378 @default.
• W3138987997 cites W2171223421 @default.
• W3138987997 cites W2190814680 @default.
• W3138987997 cites W2293030726 @default.
• W3138987997 cites W2522236431 @default.
• W3138987997 cites W2564217539 @default.
• W3138987997 cites W2587517081 @default.
• W3138987997 cites W2625311319 @default.
• W3138987997 cites W2626731085 @default.
• W3138987997 cites W2687439292 @default.
• W3138987997 cites W2734623137 @default.
• W3138987997 cites W2746548164 @default.
• W3138987997 cites W2750409457 @default.
• W3138987997 cites W2758315038 @default.
• W3138987997 cites W2780194508 @default.
• W3138987997 cites W2791115421 @default.
• W3138987997 cites W2793138409 @default.
• W3138987997 cites W2794245536 @default.
• W3138987997 cites W2799815882 @default.
• W3138987997 cites W2802367205 @default.
• W3138987997 cites W2802600358 @default.
• W3138987997 cites W2895239216 @default.
• W3138987997 cites W2898112071 @default.
• W3138987997 cites W2911105986 @default.
• W3138987997 cites W2919648530 @default.
• W3138987997 cites W2921373673 @default.
• W3138987997 cites W2923697933 @default.
• W3138987997 cites W2932048204 @default.
• W3138987997 cites W2943691611 @default.
• W3138987997 cites W2948880437 @default.
• W3138987997 cites W2951587841 @default.
• W3138987997 cites W2966748408 @default.
• W3138987997 cites W2995463243 @default.
• W3138987997 cites W3005321388 @default.
• W3138987997 cites W3008227023 @default.
• W3138987997 cites W3039385544 @default.
• W3138987997 cites W611597605 @default.
• W3138987997 doi "https://doi.org/10.1093/toxsci/kfab033" @default.
• W3138987997 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33749749" @default.
• W3138987997 hasPublicationYear "2021" @default.
• W3138987997 type Work @default.
• W3138987997 sameAs 3138987997 @default.
• W3138987997 citedByCount "3" @default.
• W3138987997 countsByYear W31389879972022 @default.
• W3138987997 crossrefType "journal-article" @default.
• W3138987997 hasAuthorship W3138987997A5014671405 @default.
• W3138987997 hasAuthorship W3138987997A5021354881 @default.
• W3138987997 hasAuthorship W3138987997A5024475164 @default.
• W3138987997 hasAuthorship W3138987997A5042598436 @default.
• W3138987997 hasAuthorship W3138987997A5065824710 @default.
• W3138987997 hasAuthorship W3138987997A5088270828 @default.
• W3138987997 hasConcept C121608353 @default.
• W3138987997 hasConcept C126322002 @default.
• W3138987997 hasConcept C134018914 @default.
• W3138987997 hasConcept C143998085 @default.
• W3138987997 hasConcept C184235292 @default.
• W3138987997 hasConcept C197934379 @default.
• W3138987997 hasConcept C2778019345 @default.
• W3138987997 hasConcept C2778695046 @default.
• W3138987997 hasConcept C2779289229 @default.
• W3138987997 hasConcept C2779490328 @default.

• next